NCT03815643 2026-03-31Avelumab Program Rollover StudyEMD SeronoPhase 3 Active not recruiting205 enrolled
NCT03228667 2026-01-14QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint InhibitorsImmunityBio, Inc.Phase 2 Active not recruiting40 enrolled